"ACC in China," a high-end academic exchange platform jointly initiated by the ACC and Bayer HealthCare Limited, aims to provide Chinese cardiovascular doctors with up-to-date information on the latest ACC Annual Scientific Session (ACC.18) and promote in-depth communication between Chinese and American physicians. This year marks the 15th anniversary of "ACC in China," with the goal of reaching more than 50 hospitals throughout China from now through May.